Skip to main content
SpringerLink
Log in

Iron Deficiency in Critically III Patients: Highlighting the Role of Hepcidin

  • Chapter
Annual Update in Intensive Care and Emergency Medicine 2011

Part of the book series: Annual Update in Intensive Care and Emergency Medicine 2011 ((AUICEM,volume 1))

  • 2123 Accesses

Abstract

Iron is a paradoxical element, essential for living organisms but also potentially toxic. Indeed, iron has the ability to readily accept and donate electrons, interconverting from soluble ferrous form (Fe2+) to the insoluble ferric form (Fe3+). This capacity allows iron to play a major role in oxygen transport (as the central part of hemoglobin) but also in electron transfer, nitrogen fixation or DNA synthesis, all essential reactions for living organisms. Indeed, iron deficiency is the main cause of anemia [1] as well as a cause of fatigue [2], [3] and decreased effort capacity [4], [5]. However, despite a high frequency of anemia among critically ill patients, with 60 to 66 % being anemic at intensive care unit (ICU) admission [6], [7], to date little is known about iron deficiency and iron metabolism in critically ill patients [8]. The interaction between inflammation and iron metabolism interferes with the usual iron metabolism variables and renders this metabolism difficult to investigate [9], [10].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Clark SF (2008) Iron deficiency anemia. Nutr Clin Pract 23: 128–141

    Article  PubMed  Google Scholar 

  2. Patterson AJ, Brown WJ, Powers JR, Roberts DC (2000) Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women’s Health. Qual Life Res 9: 491–497

    Article  PubMed  CAS  Google Scholar 

  3. Schultz BM, Freedman ML (1987) Iron deficiency in the elderly. Baillieres Clin Haematol 1: 291–313

    Article  PubMed  CAS  Google Scholar 

  4. Zhu YI, Haas JD (1997) Iron depletion without anemia and physical performance in young women. Am J Clin Nutr 66: 334–341

    PubMed  CAS  Google Scholar 

  5. Zhu YI, Haas JD (1998) Altered metabolic response of iron-depleted nonanemic women during a 15-km time trial. J Appl Physiol 84: 1768–1775

    PubMed  CAS  Google Scholar 

  6. Vincent JL, Baron JF, Reinhart K, et al (2002) Anemia and blood transfusion in critically ill patients. JAMA 288: 1499–1507

    Article  PubMed  Google Scholar 

  7. Corwin HL, Gettinger A, Pearl RG, et al (2004) The CRIT Study: Anemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 32: 39–52

    Article  PubMed  Google Scholar 

  8. Piagnerelli M, Vincent JL (2004) Role of iron in anaemic critically ill patients: it’s time to investigate! Crit Care 8: 306–307

    Article  PubMed  Google Scholar 

  9. Darveau M, Denault AY, Biais N, Notebaert E (2004) Bench-to-bedside review: iron metabolism in critically ill patients. Crit Care 8: 356–362

    Article  PubMed  Google Scholar 

  10. Pieracci FM, Barie PS (2006) Diagnosis and management of iron-related anemias in critical illness. Crit Care Med 34: 1898–1905

    Article  PubMed  Google Scholar 

  11. Nicolas G, Chauvet C, Viatte L, et al (2002) The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest 110: 1037–1044

    PubMed  CAS  Google Scholar 

  12. Hentze MW, Muckenthaler MU, Galy B, Camaschella C (2010) Two to tango: regulation of Mammalian iron metabolism. Cell 142: 24–38

    Article  PubMed  CAS  Google Scholar 

  13. Nemeth E, Tuttle MS, Powelson J, et al (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090–2093

    Article  PubMed  CAS  Google Scholar 

  14. Nemeth E, Rivera S, Gabayan V, et al (2004) IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113: 1271–1276

    PubMed  CAS  Google Scholar 

  15. Weiss G, Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352: 1011–1023

    Article  PubMed  CAS  Google Scholar 

  16. Andrews NC (2004) Anemia of inflammation: the cytokine-hepcidin link. J Clin Invest 113: 1251–1253

    PubMed  CAS  Google Scholar 

  17. Ramsay AJ, Hooper ID, Folgueras AR, Velasco G, Lopez-Otin C (2009) Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 94: 849–849

    Google Scholar 

  18. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S (2006) Suppression of hepcidin during anemia requires erythropoietic activity. Blood 108: 3730–3735

    Article  PubMed  CAS  Google Scholar 

  19. Vokurka M, Krijt J, Sulc K, Necas E (2006) Hepcidin mRNA levels in mouse liver respond to inhibition of erythropoiesis. Physiol Res 55: 667–674

    PubMed  CAS  Google Scholar 

  20. Tanno T, Bhanu NV, Oneal PA, et al (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13: 1096–1101

    Article  PubMed  CAS  Google Scholar 

  21. Hill SR, Carless PA, Henry DA, et al (2002) Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Dat Syst Rev: CD002042

    Google Scholar 

  22. Walsh TS, Lee RJ, Maciver CR, et al (2006) Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med 32: 100–109

    Article  PubMed  Google Scholar 

  23. Bateman AP, McArdle F, Walsh TS (2009) Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis. Crit Care Med 37: 1906–1912

    Article  PubMed  Google Scholar 

  24. Corwin HL, Krantz SB (2000) Anemia of the critically ill: “acute” anemia of chronic disease. Crit Care Med 28: 3098–3099

    Article  PubMed  CAS  Google Scholar 

  25. van Iperen CE, Gaillard CA, Kraaijenhagen RJ, Braam BG, Marx JJ, van de Wiel A (2000) Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med 28: 2773–2778

    Article  PubMed  Google Scholar 

  26. von Ahsen N, Muller C, Serke S, Frei U, Eckardt KU (1999) Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients. Crit Care Med 27: 2630–2639

    Article  Google Scholar 

  27. Wisser D, van Ackern K, Knoll E, Wisser H, Bertsch T (2003) Blood loss from laboratory tests. Clin Chem 49: 1651–1655

    Article  PubMed  CAS  Google Scholar 

  28. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL (1997) Prevalence of iron deficiency in the United States. JAMA 277: 973–976

    Article  PubMed  CAS  Google Scholar 

  29. Smieja MJ, Cook DJ, Hunt DL, Ali MA, Guyatt GH (1996) Recognizing and investigating iron-deficiency anemia in hospitalized elderly people. CMAJ 155: 691–696

    PubMed  CAS  Google Scholar 

  30. Jankowska EA, Rozentryt P, Witkowska A, et al (2010) Iron deficiency: an ominous sign in patients with systolic chronic heart failure. Eur Heart J 31: 1872–1880

    Article  PubMed  CAS  Google Scholar 

  31. Bellamy MC, Gedney JA (1998) Unrecognised iron deficiency in critical illness. Lancet 352:1903

    Article  PubMed  CAS  Google Scholar 

  32. Fernandez R, Tubau I, Masip J, Munoz L, Roig I, Artigas A (2010) Low reticulocyte hemoglobin content is associated with a higher blood transfusion rate in critically ill patients: a cohort study. Anesthesiology 112: 1211–1215

    Article  PubMed  CAS  Google Scholar 

  33. Huang H, Constante M, Layoun A, Santos MM (2009) Contribution of STAT3 and SMAD4 pathways to the regulation of hepcidin by opposing stimuli. Blood 113: 3593–3599

    Article  PubMed  CAS  Google Scholar 

  34. Lasocki S, Millot S, Andrieu V, et al (2008) Phlebotomies or erythropoietin injections allow mobilization of iron stores in a mouse model mimicking intensive care anemia. Crit Care Med 36: 2388–2394

    Article  PubMed  CAS  Google Scholar 

  35. Theurl I, Aigner E, Theurl M, et al (2009) Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 113: 5277–5286

    Article  PubMed  CAS  Google Scholar 

  36. Kroot JJ, Kemna EH, Bansal SS, et al (2009) Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica 94: 1748–1752

    Article  PubMed  CAS  Google Scholar 

  37. Cheng PP, Jiao XY, Wang XH, Lin JH, Cai YM (2010) Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med (in press)

    Google Scholar 

  38. Lasocki S, Baron G, Driss F, et al (2010) Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Med 36: 1044–1048

    Article  PubMed  CAS  Google Scholar 

  39. Zarychanski R, Turgeon AF, Mclntyre L, Fergusson DA (2007) Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials. CMAJ 177: 725–734

    Article  PubMed  Google Scholar 

  40. Brutsaert TD, Hernandez-Cordero S, Rivera J, Viola T, Hughes G, Haas JD (2003) Iron supplementation improves progressive fatigue resistance during dynamic knee extensor exercise in iron-depleted, nonanemic women. Am J Clin Nutr 77: 441–448

    PubMed  CAS  Google Scholar 

  41. Anker SD, Comin Colet J, Filippatos G, et al (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 361: 2436–2448

    Article  PubMed  CAS  Google Scholar 

  42. Javadi P, Buchman TG, Stromberg PE, et al (2004) High-dose exogenous iron following cecal ligation and puncture increases mortality rate in mice and is associated with an increase in gut epithelial and splenic apoptosis. Crit Care Med 32: 1178–1185

    Article  PubMed  CAS  Google Scholar 

  43. Driss F, Vrtovsnik F, Katsahian S, et al (2005) Effects of intravenous polymaltose iron on oxidant stress and non-transferrin-bound iron in hemodialysis patients. Nephron Clin Pract 99: C63–67

    Article  PubMed  CAS  Google Scholar 

  44. Marx JJ (2002) Iron and infection: competition between host and microbes for a precious element. Best Pract Res Clin Haematol 15: 411–426

    PubMed  CAS  Google Scholar 

  45. Hoen B, Paul-Dauphin A, Kessler M (2002) Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients. Clin Nephrol 57: 457–461

    PubMed  CAS  Google Scholar 

  46. Dallman PR (1987) Iron deficiency and the immune response. Am J Clin Nutr 46: 329–334

    PubMed  CAS  Google Scholar 

  47. Auerbach M, Ballard H, Glaspy J (2007) Clinical update: intravenous iron for anaemia. Lancet 369: 1502–1504

    Article  PubMed  Google Scholar 

  48. Notebaert E, Chauny JM, Albert M, Fortier S, Leblanc N, Williamson DR (2007) Shortterm benefits and risks of intravenous iron: a systematic review and meta-analysis. Transfusion 47: 1905–1918

    Article  PubMed  CAS  Google Scholar 

  49. Pieracci FM, Henderson P, Rodney JR, et al (2009) Randomized, double-blind, placebo-controlled trial of effects of enteral iron supplementation on anemia and risk of infection during surgical critical illness. Surg Infect (Larchmt) 10: 9–19

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département d’Anesthésie-Réanimation Chirurgicale, CHU Bichat-Claude Bernard, 46 rue Henri Huchard, 75018, Paris, France

    N. Heming, P. Montravers & S. Lasocki

Authors
  1. N. Heming
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Montravers
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Lasocki
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care, Erasme Hospital, Université libre de Bruxelles, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Heming, N., Montravers, P., Lasocki, S. (2011). Iron Deficiency in Critically III Patients: Highlighting the Role of Hepcidin. In: Vincent, JL. (eds) Annual Update in Intensive Care and Emergency Medicine 2011. Annual Update in Intensive Care and Emergency Medicine 2011, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18081-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18081-1_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-18080-4

  • Online ISBN: 978-3-642-18081-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation